A government committee has identified various essential drugs including key antibiotics such as amoxicillin, moxifloxacin, doxycycline and TB drug rifampicin that could run out as supplies of bulk raw materials from China have been disrupted because of Covid-19 outbreak. A high-level government committee, which submitted its report to the Department of Pharmaceuticals (DoP) last week, reviewed 54 drugs and said that out of these, 34 have no alternative.
